Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia

Condition:   Bronchopulmonary Dysplasia Intervention:   Drug: Evaluation at 24 months corrected age: respiratory outcome, Neurodevelopmental outcome, Growth outcome Sponsor:   Hospices Civils de Lyon Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials